4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-25-009116
Director gave up 33,750 shares (to pay taxes)
- Director acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEINSTEIN ROBERT Director | 2025-12-12 | Grant or award | +75,000 | 75,000 | D: show line 1 in the form | ||
| WEINSTEIN ROBERT Director | 2025-12-12 | Shares withheld for taxes | −33,750 | $1.02 | $34,425 | 41,250 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WEINSTEIN ROBERT Director | 2025-04-25 | Grant or award · Stock Option (Right to Buy) | +63,233 | 63,233 | D: show line 3 in the form |
Loading xslF345X05/ownership.xml…